127 related articles for article (PubMed ID: 20508289)
1. Modulation of P-glycoprotein activity by the substituted quinoxalinone compound QA3 in adriamycin-resistant K562/A02 cells.
Sun LR; Zhong JL; Cui SX; Li X; Ward SG; Shi YQ; Zhang XF; Cheng YN; Gao JJ; Qu XJ
Pharmacol Rep; 2010; 62(2):333-42. PubMed ID: 20508289
[TBL] [Abstract][Full Text] [Related]
2. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
[TBL] [Abstract][Full Text] [Related]
3. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
4. Sodium azulene sulfonate reverses multidrug resistance in K562/A02 cells.
Wang Z; Zhou N; Zhao J; Zhang X
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):105-110. PubMed ID: 31880526
[TBL] [Abstract][Full Text] [Related]
5. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
Han F; Liu G; Sun C; Wei J
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
[TBL] [Abstract][Full Text] [Related]
6. L1EPO, a novel podophyllotoxin derivative overcomes P-glycoprotein-mediated multidrug resistance in K562/A02 cell line.
Chen H; Wang J; Zhang J; Wang Y; Cao B; Bai S; Yu PF; Bi W; Xie W
Biol Pharm Bull; 2009 Apr; 32(4):609-13. PubMed ID: 19336892
[TBL] [Abstract][Full Text] [Related]
7. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6.
Zhu HJ; Wang JS; Guo QL; Jiang Y; Liu GQ
Biol Pharm Bull; 2005 Oct; 28(10):1974-8. PubMed ID: 16204958
[TBL] [Abstract][Full Text] [Related]
8. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX
Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528
[TBL] [Abstract][Full Text] [Related]
9. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
[TBL] [Abstract][Full Text] [Related]
10. Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II.
Xue X; Qu XJ; Gao ZH; Sun CC; Liu HP; Zhao CR; Cheng YN; Lou HX
Invest New Drugs; 2012 Feb; 30(1):212-22. PubMed ID: 20924640
[TBL] [Abstract][Full Text] [Related]
11. Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
Qiu Q; Shi W; Li Z; Zhang B; Pan M; Cui J; Dai Y; Huang W; Qian H
J Med Chem; 2017 Apr; 60(7):2930-2943. PubMed ID: 28301155
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells.
Cai Y; Lu J; Miao Z; Lin L; Ding J
Cancer Biol Ther; 2007 Nov; 6(11):1794-9. PubMed ID: 18032928
[TBL] [Abstract][Full Text] [Related]
13. [Study on reversing mechanism of multidrug resistance of K562/A02 cell line by carnosic acid].
Yu XN; Li H; Chen XL; Li XX; Wang R; Gao F
Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):381-4. PubMed ID: 21122352
[TBL] [Abstract][Full Text] [Related]
14. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
15. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
16. [Reversal Effect of Dihydromyricetin on Drug Resistance of K562/A02 Cell Line to Adriamycin].
Li BR; Wang L; Han WN; Xia LQ; Tang S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1369-1374. PubMed ID: 27784359
[TBL] [Abstract][Full Text] [Related]
17. Overcoming of P-glycoprotein-mediated multidrug resistance in K562/A02 cells using riccardin F and pakyonol, bisbibenzyl derivatives from liverworts.
Ji M; Shi Y; Lou H
Biosci Trends; 2011; 5(5):192-7. PubMed ID: 22101374
[TBL] [Abstract][Full Text] [Related]
18. Designed P-glycoprotein inhibitors with triazol-tetrahydroisoquinoline-core increase doxorubicin-induced mortality in multidrug resistant K562/A02 cells.
Kairuki M; Qiu Q; Pan M; Li Q; Zhou J; Ghaleb H; Huang W; Qian H; Jiang C
Bioorg Med Chem; 2019 Aug; 27(15):3347-3357. PubMed ID: 31202598
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Pharmacological Characterization of N-(4-(2 (6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)yl)ethyl)phenyl)quinazolin-4-amine Derivatives: Novel Inhibitors Reversing P-Glycoprotein-Mediated Multidrug Resistance.
Qiu Q; Liu B; Cui J; Li Z; Deng X; Qiang H; Li J; Liao C; Zhang B; Shi W; Pan M; Huang W; Qian H
J Med Chem; 2017 Apr; 60(8):3289-3302. PubMed ID: 28355069
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02].
Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC
Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
